Clinical trials
Phase 3 Rheumatic Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Regeneron Pharmaceuticals | 3 |
| Novartis Pharmaceuticals | 2 |
| Organogenesis | 2 |
| Pfizer | 2 |
| Tonix Pharmaceuticals, Inc. | 2 |
| Amgen | 1 |
| Janssen Research & Development, LLC | 1 |
| VA Office of Research and Development | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rheumatic Diseases | 14 |
| Arthritis | 10 |
| Joint Diseases | 9 |
| Musculoskeletal Diseases | 9 |
| Gout | 5 |
| Osteoarthritis | 4 |
| Genetic Diseases, Inborn | 3 |
| Metabolic Diseases | 3 |
| Metabolism, Inborn Errors | 3 |
| Osteoarthritis, Knee | 3 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.